committed to personalized treatment.
We believe that truly personalized medicine can only exist when the right drug is taken at the right dose.
Founded in 2004, Saladax Biomedical, Inc. is a privately held company headquartered as an anchor tenant at Ben Franklin TechVentures® located in Bethlehem, PA. Saladax develops rapid blood tests to increase the impact of personalized medicine by bringing adherence testing to psychiatrists and chemotherapeutic drug monitoring to oncologists. Additionally, the company collaborates with leading pharmaceutical companies to develop tests for clinical trials and companion diagnostics. Go to MyCareTests.com to view Saladax’s MyCare Psychiatry and MyCare Oncology lines of reagents.






Board of Directors
Managing Director, Excel Venture Management
Salvatore J. Salamone, PhD, CEO
Saladax Biomedical
Joel Zhang, Director
Fosun Pharmaceutical Group
Guan Xiaohui, Director
Fosun Pharmaceutical Group
Michael Esposito, Director
Norbridge, Inc.
David M. Brewer, Director
Columbia Ventures Corporation
Scientific Advisory Board
Chair, Professor of Medicine, Pharmacology & Medical Biology – University of Pittsburgh School of Medicine
Joseph R. Bertino, MD
Associate Director, The Cancer Institute of New Jersey
Alec Goldenberg, MD
Director, Hematology Clinic and Hepatoma Tumor Study Group, Bellevue Hospital, NYU Medical Center
Li Zhang, MD
Professor of Medical Oncology and Deputy Director of Lung Cancer Research Center at Sun Yat-Sen University
Howard McLeod, PharmD
Medical Director, DeBartolog Family Personalized Medicine Institute at the Moffitt Cancer Center
Ralph Aquila, MD
Medical Director, Fountain Hous, Sidney R. Baer Jry